Activation of FXR promotes intestinal metaplasia of gastric cells via SHP‑dependent upregulation of the expression of CDX2

Zhou,Haining; Ni,Zhen; Li,Ting; Su,Linna; Zhang,Lianfeng; Liu,Na; Shi,Yongquan

doi:10.3892/ol.2018.8342

Activation of FXR promotes intestinal metaplasia of gastric cells via SHP‑dependent upregulation of the expression of CDX2

Authors:
- Haining Zhou
- Zhen Ni
- Ting Li
- Linna Su
- Lianfeng Zhang
- Na Liu
- Yongquan Shi
View Affiliations

Affiliations: State Key Laboratory of Cancer Biology and Institute of Digestive Diseases, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China, Department of Gastroenterology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China
Published online on: March 23, 2018 https://doi.org/10.3892/ol.2018.8342
Pages: 7617-7624
Copyright: © Zhou et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Gastric intestinal metaplasia (IM) induced by bile acid is a precancerous lesion of gastric adenocarcinoma and is associated with the expression of caudal‑related homeobox 2 (CDX2). In the present study, the role of farnesoid X receptor (FXR) on the regulation of CDX2 in gastric cells was investigated and the underlying molecular mechanisms were examined. Human gastric cell lines were treated with chenodeoxycholic acid (CDCA) or FXR agonist GW4064. Cells were treated with CDCA in the presence or absence of the FXR antagonist or FXR siRNA transfection. Next, cells were treated with CDCA in the presence or absence of SHP siRNA transfection and FXR, CDX2 and SHP mRNA and protein levels were determined by reverse transcription‑quantitative polymerase chain reaction and western blot analysis. A chromatin immunoprecipitation assay was performed to examine the relationship between FXR and SHP and the expressions of FXR and CDX2 in gastritis and IM tissues were detected using immunohistochemistry. The results revealed that CDCA was able to induce CDX2 expression, which could be blocked by inhibition or knockdown of FXR. Mechanistically, FXR directly induced the expression of small heterodimer partner (SHP). SHP knockdown significantly decreased CDCA‑induced CDX2 expression. ChIP results indicated that FXR could directly bind SHP promoter and promote SHP expression. Finally, immunohistochemistry results demonstrated that the expression levels of CDX2 and FXR in human IM lesions were significantly higher, compared with those in gastritis lesions, and were positively correlated. Collectively, these results revealed that the activation of FXR and sequential direct transcriptional induction of SHP were involved in the expression of CDX2 induced by bile acid in gastric IM lesions.

View Figures

View References

1	Correa P, Piazuelo MB and Wilson KT: Pathology of gastric intestinal metaplasia: Clinical implications. Am J Gastroenterol. 105:493–498. 2010. View Article : Google Scholar : PubMed/NCBI
2	Hryniuk A, Grainger S, Savory JG and Lohnes D: Cdx function is required for maintenance of intestinal identity in the adult. Dev Biol. 363:426–437. 2012. View Article : Google Scholar : PubMed/NCBI
3	Silberg DG, Swain GP, Suh ER and Traber PG: Cdx1 and cdx2 expression during intestinal development. Gastroenterology. 119:961–971. 2000. View Article : Google Scholar : PubMed/NCBI
4	Xin S, Huixin C, Benchang S, Aiping B, Jinhui W, Xiaoyan L, Yu WB and Minhu C: Expression of Cdx2 and claudin-2 in the multistage tissue of gastric carcinogenesis. Oncology. 73:357–365. 2007. View Article : Google Scholar : PubMed/NCBI
5	Silberg DG, Sullivan J, Kang E, Swain GP, Moffett J, Sund NJ, Sackett SD and Kaestner KH: Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice. Gastroenterology. 122:689–696. 2002. View Article : Google Scholar : PubMed/NCBI
6	Li S, Chen X, Zhou L and Wang BM: Farnesoid X receptor signal is involved in deoxycholic acid-induced intestinal metaplasia of normal human gastric epithelial cells. Oncol Rep. 34:2674–2682. 2015. View Article : Google Scholar : PubMed/NCBI
7	Xu Y, Watanabe T, Tanigawa T, Machida H, Okazaki H, Yamagami H, Watanabe K, Tominaga K, Fujiwara Y, Oshitani N and Arakawa T: Bile acids induce cdx2 expression through the farnesoid x receptor in gastric epithelial cells. J Clin Biochem Nutr. 46:81–86. 2010. View Article : Google Scholar : PubMed/NCBI
8	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–428. 2001. View Article : Google Scholar : PubMed/NCBI
9	Matsubara T, Li F and Gonzalez FJ: FXR signaling in the enterohepatic system. Mol Cell Endocrinol. 368:17–29. 2013. View Article : Google Scholar : PubMed/NCBI
10	Urizar NL, Liverman AB, Dodds DT, Silva FV, Ordentlich P, Yan Y, Gonzalez FJ, Heyman RA, Mangelsdorf DJ and Moore DD: A natural product that lowers cholesterol as an antagonist ligand for FXR. Science. 296:1703–1706. 2002. View Article : Google Scholar : PubMed/NCBI
11	Park MJ, Kim KH, Kim HY, Kim K and Cheong J: Bile acid induces expression of COX-2 through the homeodomain transcription factor CDX1 and orphan nuclear receptor SHP in human gastric cancer cells. Carcinogenesis. 29:2385–2393. 2008. View Article : Google Scholar : PubMed/NCBI
12	Tatsugami M, Ito M, Tanaka S, Yoshihara M, Matsui H, Haruma K and Chayama K: Bile acid promotes intestinal metaplasia and gastric carcinogenesis. Cancer Epidemiol Biomarkers Prev. 21:2101–2107. 2012. View Article : Google Scholar : PubMed/NCBI
13	Matsuhisa T and Tsukui T: Relation between reflux of bile acids into the stomach and gastric mucosal atrophy, intestinal metaplasia in biopsy specimens. J Clin Biochem Nutr. 50:217–221. 2012. View Article : Google Scholar : PubMed/NCBI
14	Matsuhisa T, Arakawa T, Watanabe T, Tokutomi T, Sakurai K, Okamura S, Chono S, Kamada T, Sugiyama A, Fujimura Y, et al: Relation between bile acid reflux into the stomach and the risk of atrophic gastritis and intestinal metaplasia: A multicenter study of 2283 cases. Dig Endosc. 25:519–525. 2013. View Article : Google Scholar : PubMed/NCBI
15	Mutoh H, Hayakawa H, Sakamoto H, Sashikawa M and Sugano K: Transgenic Cdx2 induces endogenous Cdx1 in intestinal metaplasia of Cdx2-transgenic mouse stomach. FEBS J. 276:5821–5831. 2009. View Article : Google Scholar : PubMed/NCBI
16	Cooke G, Blanco-Fernandez A and Seery JP: The effect of retinoic acid and deoxycholic acid on the differentiation of primary human esophageal keratinocytes. Dig Dis Sci. 53:2851–2857. 2008. View Article : Google Scholar : PubMed/NCBI
17	Camilo V, Barros R, Sousa S, Magalhães AM, Lopes T, Santos Mário A, Pereira T, Figueiredo C, David L and Almeida R: Helicobacter pylori and the BMP pathway regulate CDX2 and SOX2 expression in gastric cells. Carcinogenesis. 33:1985–1992. 2012. View Article : Google Scholar : PubMed/NCBI
18	Duan JH and Fang L: MicroRNA-92 promotes gastric cancer cell proliferation and invasion through targeting FXR. Tumour Biol. 35:11013–11019. 2014. View Article : Google Scholar : PubMed/NCBI
19	Gadaleta RM, Cariello M, Sabba C and Moschetta A: Tissue-specific actions of FXR in metabolism and cancer. Biochim Biophys Acta. 1851:30–39. 2015. View Article : Google Scholar : PubMed/NCBI
20	Lian F, Xing X, Yuan G, Schäfer C, Rauser S, Walch A, Röcken C, Ebeling M, Wright MB, Schmid RM, et al: Farnesoid X receptor protects human and murine gastric epithelial cells against inflammation-induced damage. Biochem J. 438:315–323. 2011. View Article : Google Scholar : PubMed/NCBI
21	Fiorucci S, Mencarelli A, Cipriani S, Renga B, Palladino G, Santucci L and Distrutti E: Activation of the farnesoid-X receptor protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs in mice. Br J Pharmacol. 164:1929–1938. 2011. View Article : Google Scholar : PubMed/NCBI
22	Capello A, Moons LM, Van de Winkel A, Siersema PD, van Dekken H, Kuipers EJ and Kusters JG: Bile acid-stimulated expression of the farnesoid X receptor enhances the immune response in Barrett esophagus. Am J Gastroenterol. 103:1510–1516. 2008. View Article : Google Scholar : PubMed/NCBI
23	Yasuda H, Hirata S, Inoue K, Mashima H, Ohnishi H and Yoshiba M: Involvement of membrane-type bile acid receptor M-BAR/TGR5 in bile acid-induced activation of epidermal growth factor receptor and mitogen-activated protein kinases in gastric carcinoma cells. Biochem Biophys Res Commun. 354:154–159. 2007. View Article : Google Scholar : PubMed/NCBI
24	Cao W, Tian W, Hong J, Li D, Tavares R, Noble L, Moss SF and Resnick MB: Expression of bile acid receptor TGR5 in gastric adenocarcinoma. Am J Physiol Gastrointest Liver Physiol. 304:G322–G327. 2013. View Article : Google Scholar : PubMed/NCBI
25	Centuori SM, Gomes CJ, Trujillo J, Borg J, Brownlee J, Putnam CW and Martinez JD: Deoxycholic acid mediates non-canonical EGFR-MAPK activation through the induction of calcium signaling in colon cancer cells. Biochim Biophys Acta. 1861:663–670. 2016. View Article : Google Scholar : PubMed/NCBI
26	Werneburg NW, Yoon JH, Higuchi H and Gores GJ: Bile acids activate EGF receptor via a TGF-alpha-dependent mechanism in human cholangiocyte cell lines. Am J Physiol Gastrointest Liver Physiol. 285:G31–G36. 2003. View Article : Google Scholar : PubMed/NCBI
27	Hoeke MO, Heegsma J, Hoekstra M, Moshage H and Faber KN: Human FXR regulates SHP expression through direct binding to an LRH-1 binding site, independent of an IR-1 and LRH-1. PLoS One. 9:e880112014. View Article : Google Scholar : PubMed/NCBI
28	Park WI, Park MJ, An JK, Choi YH, Kim HY, Cheong J and Yang US: Bile acid regulates c-Jun expression through the orphan nuclear receptor SHP induction in gastric cells. Biochem Biophys Res Commun. 369:437–443. 2008. View Article : Google Scholar : PubMed/NCBI
29	Barros R, da Costa LT, Pinto-de-Sousa J, Duluc I, Freund JN, David L and Almeida R: CDX2 autoregulation in human intestinal metaplasia of the stomach: Impact on the stability of the phenotype. Gut. 60:290–298. 2011. View Article : Google Scholar : PubMed/NCBI